EODData

MEMBERSHIP REGISTER LOG IN

SHG, 688621: Beijing Sun Novo Pharmaceutical Research Co Ltd

01 Dec 2025
LAST:

65.71

CHANGE:
 0.44		OPEN:
66.00		HIGH:
66.33		ASK:
0.00		VOLUME:
2.67M
CHG(%):
0.67		PREV:
66.15		LOW:
64.74		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
01 Dec 2566.0066.3364.7465.712.67M
28 Nov 2567.3267.5564.6866.154.04M
27 Nov 2567.8668.8966.6068.005.42M
26 Nov 2563.7070.0063.7068.557.88M
25 Nov 2562.2864.5061.5163.694.72M
24 Nov 2562.4662.9660.0062.314.29M
21 Nov 2558.5762.8058.5761.218.63M
20 Nov 2557.1259.5057.1258.592.68M
19 Nov 2559.0061.0257.0057.113.33M
18 Nov 2559.1959.8058.5159.451.77M

PROFILE

Name:Beijing Sun Novo Pharmaceutical Research Co Ltd
About:Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China. The company operates external preparation platform that focuses on the research and development of new drugs and generic drugs for skin external preparations; children's clinical data bridging research center; pediatric drug research and development platform; pediatric drug delivery dosage research and development platform; respiratory tract drug delivery and topical preparation platforms; polypeptide and other drug molecular design and development platform; genotoxic impurity detection platform; technology platform for slow and controlled release preparations; drug synthesis platform; and synthesis technology platform. It also offers SMO, clinical quality management, data management and statistical analysis, project management, test center, clinical research center, clinical trials, TMFDocument management, quality control, Medical Writing, medical monitoring, and pharmacovigilance services; and registration-related services for chemical drugs, biological products, and medical device products. In addition, the company operates quantitative pharmacology platform that use technology on pharmacokinetics, pharmacodynamics, body function, disease mechanism and test process, and other information for quantitative research; and mass spectrometry, immunological analysis, cell biology, and molecular biology platforms that provide biological analysis services for large and small molecular drugs, as well as operates as a Contract Research Organization for Professional Peptide Drug Research and Development. Beijing Sun-Novo Pharmaceutical Research Co., Ltd. was founded in 2009 and is based in Beijing, China.
Sector:Healthcare
Address:Building 7, Beijing, China, 102200
Website:https://www.sun-novo.com
ISIN:CNE100005139

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:46.22 
Price to Sales:6.21 
Price to Book:5.27 
Profit Margin:0.13 
Operating Margin:0.33 
Return on Assets:0.06 
Return on Equity:0.11 
DivYield:0.00 
Div/Share:0.16 
Revenue:1.018B 
EBITDA:286.4M 
Shares:112.0M 
Market Cap:7.36B 

TECHNICAL INDICATORS

MA5:66.421.1%
MA10:63.084.2%
MA20:60.618.4%
MA50:64.072.6%
MA100:64.282.2%
MA200:54.9119.7%
STO9:66.72
STO14:66.72
RSI14:65.84 
WPR14:-24.83
MTM14:4.29
ROC14:0.07 
ATR:2.94 
Week High:70.006.5%
Week Low:60.009.5%
Month High:70.006.5%
Month Low:54.8319.7%
Year High:86.5031.6%
Year Low:33.0099.1%
Volatility:16.34 

RECENT SPLITS

Date Ratio
12 May 20231-1

RECENT DIVIDENDS

Date Amount
11 Jun 2025$0.16
09 Jul 2024$0.17
12 May 2023$0.60